Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Feb 24, 2024 1:25pm
121 Views
Post# 35897258

RE:I wonder …

RE:I wonder …That magical $4 price target that appeared in fall of 2021 if memory serves (Paradigm has scrubbed it -so it will be tough to find). 

 
That was right after Seto's dubious ascension to CEO. Seto used to work at Paradigm you know... and the two have made serious money of Spectral (arguably the only two).

Back then the float was around 230 million shares- but now Paradigm is using 404 million as their fully diluted float. (Seto has been working hard it seems- uff). You can do the math MM- but maybe somewhere in that  40%-ish dilution is the equity value you seek.

Also the $4.target was pointed out as laughable at the time- as it came out around October and they predicted that insane spike to $4. in price by EOY or within 3 months. Rubes searching for rubes.

Clearly, nothing even close to that happened (I think the price ended down at EOY), and everyone who witnessed it will always know what game Paradigm is playing.



<< Previous
Bullboard Posts
Next >>